We are live on ! Find out more
MSS

Mitchell Sinkler & Starr Portfolio holdings

AUM $240M
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+0.89%
1 Year Est. Return
+24.63%
3 Year Est. Return
+72.22%
5 Year Est. Return
+87.27%
10 Year Est. Return
+266.58%
AUM
$375M
AUM Growth
-$22.9M
Cap. Flow
-$50.6M
Cap. Flow %
-13.5%
Top 10 Hldgs %
36.29%
Holding
196
New
7
Increased
33
Reduced
65
Closed
6

Top Sells

Rank Stock Value
1
HD icon
Home Depot
HD
+$7.32M
2
SYK icon
Stryker
SYK
+$4.3M
3
ADP icon
Automatic Data Processing
ADP
+$3.28M
4
CL icon
Colgate-Palmolive
CL
+$2.63M
5
JNJ icon
Johnson & Johnson
JNJ
+$2.59M

Sector Composition

Rank Sector Weight
1 Technology 24.31%
2 Healthcare 11.61%
3 Financials 10.32%
4 Industrials 9.26%
5 Consumer Staples 8.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPN icon
151
Global Payments
GPN
$22.1B
$222K 0.06%
1,983
DXCM icon
152
DexCom
DXCM
$27.6B
$221K 0.06%
+2,838
New +$210K
XLK icon
153
State Street Technology Select Sector SPDR ETF
XLK
$115B
$209K 0.06%
1,800
EW icon
154
Edwards Lifesciences
EW
$47.6B
$207K 0.06%
+2,800
New +$196K
PYPL icon
155
PayPal
PYPL
$49.5B
$205K 0.05%
+2,400
New +$202K
XLY icon
156
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.4B
$196K 0.05%
1,750
VEU icon
157
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$185K 0.05%
3,215
VCR icon
158
Vanguard Consumer Discretionary ETF
VCR
$5.84B
$156K 0.04%
415
DES icon
159
WisdomTree US SmallCap Dividend Fund
DES
$2.19B
$154K 0.04%
4,478
VFH icon
160
Vanguard Financials ETF
VFH
$13.3B
$153K 0.04%
1,296
SCHA icon
161
Schwab U.S Small- Cap ETF
SCHA
$22.5B
$140K 0.04%
5,400
-600
-10% -$16K
VIS icon
162
Vanguard Industrials ETF
VIS
$8.23B
$138K 0.04%
544
VDE icon
163
Vanguard Energy ETF
VDE
$10.1B
$137K 0.04%
1,126
IUSG icon
164
iShares Core S&P US Growth ETF
IUSG
$31.1B
$128K 0.03%
920
VV icon
165
Vanguard Large-Cap ETF
VV
$51.9B
$99.8K 0.03%
370
VHT icon
166
Vanguard Health Care ETF
VHT
$18.2B
$98.9K 0.03%
390
DON icon
167
WisdomTree US MidCap Dividend Fund
DON
$4.03B
$91.7K 0.02%
1,800
VWO icon
168
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$88.1K 0.02%
2,001
TLT icon
169
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
$87.3K 0.02%
1,000
IBB icon
170
iShares Biotechnology ETF
IBB
$9.31B
$85K 0.02%
643
IGPT icon
171
Invesco AI and Next Gen Software ETF
IGPT
$1.21B
$80.9K 0.02%
1,788
SPSB icon
172
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
$80.2K 0.02%
+2,685
New +$80.5K
IWD icon
173
iShares Russell 1000 Value ETF
IWD
$82B
$79.6K 0.02%
430
VONG icon
174
Vanguard Russell 1000 Growth ETF
VONG
$42.5B
$67.1K 0.02%
650
+100
+18% +$10.1K
SPHQ icon
175
Invesco S&P 500 Quality ETF
SPHQ
$19.4B
$67K 0.02%
1,000

Similar funds

Mitchell Sinkler & Starr's Q4 2024 Portfolio in Review

As of Q4 2024, Mitchell Sinkler & Starr held 196 positions worth $375M, down 5.8% from $398M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Mitchell Sinkler & Starr withdrew a net $50.6M in Q4 2024, closing 6 positions and reducing 65 holdings. Its most notable exit was HCA Healthcare, an estimated $268K position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Mitchell Sinkler & Starr opened a new position in DexCom worth $221K.

  • Mitchell Sinkler & Starr's largest Q4 2024 buy was DexCom: 2,838 shares worth $221K.
  • Mitchell Sinkler & Starr added most to Alphabet (Google) Class A in Q4 2024, an estimated $410K increase.
  • Mitchell Sinkler & Starr's biggest Q4 2024 reduction was Home Depot, cutting an estimated $7.32M.
  • Mitchell Sinkler & Starr fully exited HCA Healthcare in Q4 2024, selling an estimated $268K.
  • Mitchell Sinkler & Starr's ten largest holdings make up 36% of its $375M portfolio in Q4 2024.
  • Mitchell Sinkler & Starr opened 7 new positions and closed 6 in Q4 2024.
  • Mitchell Sinkler & Starr's portfolio value fell 5.8% quarter-over-quarter to $375M.

Based on Mitchell Sinkler & Starr's 13F filing for Q4 2024, filed 12 Feb 2025.